Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17,691Revenue $M5,501Net Margin (%)16.2Z-Score3.3
Enterprise Value $M20,373EPS $2.5Operating Margin %19.1F-Score4
P/E(ttm))20.1Cash Flow Per Share $4.4Pre-tax Margin (%)17.7Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %11.3Quick Ratio1.9Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %-0.3Current Ratio2.3Lower Leverage y-yN
Price/Cash Flow8.0y-y EBITDA Growth Rate %25.7ROA % (ttm)8.9Higher Current Ratio y-yN
Dividend Yield %1.7Insider Buy (3m)0ROE % (ttm)22.2Less Shares Outstanding y-yN
Payout Ratio %34.0Shares Outstanding M284ROI % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with STJ

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
STJMario Gabelli 2014-06-30 Add0.01%$61.64 - $70.46
($64.76)
$ 62.14-4%Add 201.61%37,400
STJJoel Greenblatt 2014-06-30 Buy $61.64 - $70.46
($64.76)
$ 62.14-4%New holding, 4264 sh.4,264
STJVanguard Health Care Fund 2014-06-30 Reduce-0.29%$61.64 - $70.46
($64.76)
$ 62.14-4%Reduce -26.41%4,301,100
STJJohn Hussman 2014-06-30 Reduce-0.25%$61.64 - $70.46
($64.76)
$ 62.14-4%Reduce -16.67%250,000
STJDavid Dreman 2014-06-30 Reduce-0.08%$61.64 - $70.46
($64.76)
$ 62.14-4%Reduce -32.77%31,736
STJDavid Dreman 2014-03-31 Add0.1%$59.4 - $68.48
($64.99)
$ 62.14-4%Add 71.71%47,202
STJJohn Hussman 2014-03-31 Reduce-0.21%$59.4 - $68.48
($64.9)
$ 62.14-4%Reduce -14.29%300,000
STJJoel Greenblatt 2014-03-31 Sold Out -0.03%$59.4 - $68.48
($64.99)
$ 62.14-4%Sold Out0
STJMario Gabelli 2014-03-31 Reduce-0.02%$59.4 - $68.48
($64.99)
$ 62.14-4%Reduce -83.06%12,400
STJJohn Hussman 2013-12-31 Buy 1.5%$54.58 - $62.74
($57.9)
$ 62.147%New holding, 350000 sh.350,000
STJDavid Dreman 2013-12-31 Reduce-0.11%$54.58 - $62.74
($57.9)
$ 62.147%Reduce -44.61%27,489
STJJoel Greenblatt 2013-12-31 Reduce-0.02%$54.58 - $62.74
($57.9)
$ 62.147%Reduce -36.01%17,326
STJVanguard Health Care Fund 2013-09-30 Reduce-0.16%$45.6 - $54.03
($51.56)
$ 62.1420%Reduce -12.98%6,297,900
STJDavid Dreman 2013-09-30 Reduce-0.12%$45.6 - $54.03
($51.56)
$ 62.1420%Reduce -62.23%49,625
STJJoel Greenblatt 2013-09-30 Reduce-0.06%$45.6 - $54.03
($51.56)
$ 62.1420%Reduce -50.12%27,075
STJRay Dalio 2013-09-30 Sold Out -0.04%$45.6 - $54.03
($51.56)
$ 62.1420%Sold Out0
STJJohn Hussman 2013-09-30 Sold Out -0.01%$45.6 - $54.03
($51.56)
$ 62.1420%Sold Out0
STJRay Dalio 2013-06-30 Reduce-0.09%$39.95 - $47
($43.33)
$ 62.1443%Reduce -69.15%105,185
STJJoel Greenblatt 2013-06-30 Reduce-0.08%$39.95 - $47
($43.33)
$ 62.1443%Reduce -40.17%54,280
STJJames Barrow 2013-03-31 Add0.06%$36.14 - $43.12
($40.68)
$ 62.1453%Add 41.47%2,735,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

STJ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
STJ Joel Greenblatt 2014-06-304,26400New Buy
STJ Mario Gabelli 2014-06-3037,4000.010.01+201.61%
STJ James Barrow 2014-06-302,940,8851.030.27+0.81%
STJ John Hussman 2014-06-30250,0000.091.3-16.67%
STJ Vanguard Health Care Fund 2014-06-304,301,1001.510.79-26.41%
STJ David Dreman 2014-06-3031,7360.010.17-32.77%
Premium Most recent portfolio changes are included for Premium Members only!


STJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Carlson MarkChief Medical Off-VP,Clinical 2014-07-30Sell1,198$66.4-6.75view
Murphy Mark W.VP, IT and CIO 2014-07-29Sell2,000$66.43-6.79view
STARKS DANIEL JChairman, CEO & President 2014-07-29Sell90,000$66.25-6.54view
Gestin Denis MPresident, Int'l Division 2014-07-28Sell99,000$66.76-7.25view
Ellingson RachelVP, Corporate Relations 2014-07-28Sell2,630$66.72-7.19view
Thome ScottVP, Global Ops & Supply Chain 2014-07-18Sell5,997$67.06-7.66view
Fecho JeffVP, Global Quality 2014-07-18Sell7,099$66.73-7.21view
Craig Angela DVP - Global Human Resources 2014-03-04Sell45,501$68-8.94view
ROUSSEAU MICHAEL TCOO 2014-02-18Sell50,000$67.08-7.69view
ROCCA MICHAEL ADirector 2014-02-06Sell5,600$60.362.58view

Press Releases about STJ :

    Quarterly/Annual Reports about STJ:

    News about STJ:

    Articles On GuruFocus.com
    No More a Simple Distributor Sep 07 2014 
    What Drives St. Jude Medical to Be More Diversified? Apr 30 2014 
    Weekly 52-Week Highs Highlight: PPG, STJ, V, LLTC, LUV Dec 23 2013 
    Renaissance Technologies - Heavy Selling in Third Quarter, AAPL, MST, STJ, Others Nov 14 2013 
    Weekly CFO Sells Highlight: TXN, AAPL, MAN, DHR, STJ, BAX Jul 29 2013 
    comment on STJ Apr 21 2013 
    Sarah Ketterer Returns 24 Pct in 2012, Her Top Q4 Buys Feb 25 2013 
    Why Cooperman and Price Are Betting on Boston Scientific’s Turnaround Dec 31 2012 
    My Best Healthcare Stock Picks For 2013 | Last Year’s Picks Gained 31.55% Dec 04 2012 
    Weekly CEO Sells Highlight: Entegris, Honeywell International, St Jude Medical and Wesco Internation Nov 05 2012 


    More From Other Websites
    8:34 am St. Jude Medical receives CE Mark approval for pacing lead labeling that will expand patient... Sep 22 2014
    St. Jude Medical Receives CE Mark Approval for Pacing Lead Labeling That Will Expand Patient Access... Sep 22 2014
    St. Jude Medical Comes Up with Positive CardioMEMS Data Sep 17 2014
    St. Jude Medical Gets Clearance for PCI Optimization System Sep 17 2014
    St. Jude Medical Gets Award for Leadless Pacemaker Again Sep 16 2014
    CardioMEMS Data Shows Pulmonary Artery Pressure Monitoring Significantly Reduces Heart Failure... Sep 15 2014
    Cramer: Your move ahead of Alibaba Sep 15 2014
    [video] Cramer: Your move ahead of Alibaba Sep 15 2014
    St. Jude Medical Reports Positive 12-Month EnligHTN Data Sep 15 2014
    St. Jude Medical Announces Launch of OPTIS Integrated System Sep 15 2014
    St. Jude Medical Nanostim Leadless Pacemaker Receives Prestigious Award at the Annual Phoenix... Sep 15 2014
    Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and... Sep 13 2014
    No More a Simple Distributor Sep 07 2014
    Positive Data on St. Jude Medical Quadripolar Lead System Sep 03 2014
    St. Jude Medical's Tech Helps Coronary Artery Patients Sep 02 2014
    Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in... Sep 02 2014
    New Clinical Trial Results Demonstrate Importance of St. Jude Medical Fractional Flow Reserve in... Sep 01 2014
    Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar... Aug 31 2014
    St. Jude Medical to Present at the Morgan Stanley Global Healthcare Conference Aug 28 2014
    St. Jude Medical Settles FDA Warnings Letter for Texas Plant Aug 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK